Cited by 340Ubiquitin and proteasome pathwaysDNA Repair MechanismsCancer-related Molecular Pathways

SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase

Open access
Jin, Jianping, Shirogane, Takahiro, Xu, Lai, Nalepa, Grzegorz, Qin, Jun, Elledge, Stephen J., Harper, J. Wade·2003·Genes & Development

Abstract

Eukaryotic cells respond to DNA damage and stalled replication forks by activating protein kinase-mediated signaling pathways that promote cell cycle arrest and DNA repair. A central target of the cell cycle arrest program is the Cdc25A protein phosphatase. Cdc25A is required for S-phase entry and dephosphorylates tyrosine-15 phosphorylated Cdk1 (Cdc2) and Cdk2, positive regulators of cell division. Cdc25A is unstable during S-phase and is degraded through the ubiquitin-proteasome pathway, but its turnover is enhanced in response to DNA damage. Although basal and DNA-damage-induced turnover depends on the ATM-Chk2 and ATR-Chk1 pathways, how these kinases engage the ubiquitin ligase machinery is unknown. Here, we demonstrate a requirement for SCF β-TRCP in Cdc25A turnover during an unperturbed cell cycle and in response to DNA damage. Depletion of β-TRCP stabilizes Cdc25A, leading to hyperactive Cdk2 activity. SCF β-TRCP promotes Chk1-dependent Cdc25A ubiquitination in vitro, and this involves serine 76, a known Chk1 phosphorylation site. However, recognition of Cdc25A by β-TRCP occurs via a noncanonical phosphodegron in Cdc25A containing phosphoserine 79 and phosphoserine 82, sites that are not targeted by Chk1. These data indicate that Cdc25A turnover is more complex than previously appreciated and suggest roles for an additional kinase(s) in Chk1-dependent Cdc25A turnover.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.1157503

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A G2-phase DNA damage response causes claspin-dependent Chk1/2 activation and SCFβTrcP-mediated degradation of Cdc25A, arresting multiple cell-cycle transitions including the G2 checkpoint.

    “The occurrence of DNA damage response in G2-phase, leads to checkpoint mediator (claspin) dependent activation of Chk1/2, followed by SCFβTrcP mediated degradation of CDK-activating phosphatase Cdc25A [341, 342], that results in arrest of multiple cell-cycle transition including the G2 checkpoint [343, 344].”

    From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [341]

    The Abstract and Discussion (page not provided) support SCFβ-TRCP-mediated Cdc25A turnover in response to DNA damage and Chk1-dependent Cdc25A ubiquitination. They do not establish claspin-dependent Chk1/2 activation specifically in G2 phase. The sentence attaches separate citations to its later claim about arresting multiple cell-cycle transitions. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S. J., & Harper, J. W.
Affiliations
  • Howard Hughes Medical Institute (US)
  • Baylor College of Medicine (US)
Venue
Genes & Development
Published
2003-01-01
Volume
17
Issue
24
Pages
3062-3074
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2153708110
Cited by
340
References
59
Citations by year
2026: 6 · 2025: 10 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 12 · 2020: 13 · 2019: 6 · 2018: 9 · 2017: 11 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 17 · 2012: 25
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • Sveriges Lantbruksuniversitet
  • Japan Science Society
  • National Institutes of Health
  • National Institute on Aging (R01AG011085)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
CDC25A, ubiquitination, protein degradation, ubiquitin ligase, DNA damage response, ATR-Chk1 pathway, ATM-Chk2 pathway, phosphodegron, cell cycle arrest, S phase entry
MeSH terms
Checkpoint Kinase 1, Binding Sites, Cells, Cultured, DNA Damage, DNA Repair, Humans, Phosphorylation, Plasmids, Protein Binding, Protein Kinases, Radiation, Ionizing, Signal Transduction, S Phase, Cyclin E, cdc25 Phosphatases, Amino Acid Motifs, Ubiquitin, CDC2-CDC28 Kinases, SKP Cullin F-Box Protein Ligases, Cyclin-Dependent Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review